X-Ray Crystallographic Structure of Rnase Po1 That Exhibits Anti-Tumor
968 Regular Article Biol. Pharm. Bull. 37(6) 968–978 (2014) Vol. 37, No. 6 X-Ray Crystallographic Structure of RNase Po1 That Exhibits Anti- tumor Activity Hiroko Kobayashi,*,a Takuya Katsutani,b Yumiko Hara,b Naomi Motoyoshi,a Tadashi Itagaki,a Fusamichi Akita,b Akifumi Higashiura,b Yusuke Yamada,c Norio Inokuchi,a and Mamoru Suzuki*,b a School of Pharmacy, Nihon University; 7–7–1 Narashinodai, Funabashi, Chiba 274–8555, Japan: b Institute for Protein Research, Osaka University; 3–2 Yamadaoka, Suita, Osaka 565–0871, Japan: and c Structural Biology Research Center, Photon Factory, Institute of Materials Structure Science, High Energy Accelerator Research Organization KEK; 1–1 Oho, Tsukuba, Ibaraki 305–0801, Japan. Received November 29, 2013; accepted March 12, 2014 RNase Po1 is a guanylic acid-specific ribonuclease member of the RNase T1 family from Pleurotus os- treatus. We previously reported that RNase Po1 inhibits the proliferation of human tumor cells, yet RNase T1 and other T1 family RNases are non-toxic. We determined the three-dimensional X-ray structure of RNase Po1 and compared it with that of RNase T1. The catalytic sites are conserved. However, there are three disul- fide bonds, one more than in RNase T1. One of the additional disulfide bond is in the catalytic and binding site of RNase Po1, and makes RNase Po1 more stable than RNase T1. A comparison of the electrostatic po- tential of the molecular surfaces of these two proteins shows that RNase T1 is anionic whereas RNase Po1 is cationic, so RNase Po1 might bind to the plasma membrane electrostatically.
[Show full text]